Stockscreener 앱 받기
2.62
0.76%
-0.02
시간 외 거래:
2.61
-0.01
-0.38%
전일 마감가:
$2.64
열려 있는:
$2.6
하루 거래량:
33,956
Relative Volume:
0.01
시가총액:
$45.25M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-4.73%
1개월 성능:
+0.00%
6개월 성능:
-34.34%
1년 성능:
-21.79%
1일 변동 폭
$2.56
$2.709
1주일 범위
$2.56
$2.77
52주 변동 폭
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
명칭
Mural Oncology Plc
전화
353 1 905 8020
주소
10 EARLSFORT TERRACE, DUBLIN 2
MURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.62 | 47.49M | 0 | 0 | 0 | 0.00 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-25 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-04-04 | 개시 | Morgan Stanley | Overweight |
Mural Oncology Plc 주식(MURA)의 최신 뉴스
Form 8.3Mural Oncology plc - Business Wire
BlackRock discloses stake in Mural Oncology By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology - Investing.com Australia
Goldman Sachs adjusts positions in Mural Oncology By Investing.com - Investing.com South Africa
Goldman Sachs adjusts positions in Mural Oncology - Investing.com Australia
Goldman Sachs reports trading in Mural Oncology shares By Investing.com - Investing.com South Africa
Mural Oncology Announces Number of Relevant Securities in Issue - The Manila Times
Mural Oncology Discloses Share Count Under Irish Takeover Rules: What's Behind This Move? - Stock Titan
Goldman Sachs reports trading in Mural Oncology shares - Investing.com Australia
Mural Oncology plc (NASDAQ:MURA) Shares Sold by Price T Rowe Associates Inc. MD - Defense World
Goldman Sachs reveals stake in biopharmaceutical firm Mural Oncology - Dimsum Daily
Goldman Sachs discloses stake in Mural Oncology By Investing.com - Investing.com South Africa
Goldman Sachs discloses stake in biopharmaceutical firm Mural Oncology - Dimsum Daily
Goldman Sachs discloses stake in Mural Oncology - Investing.com
Goldman Sachs reports dealings in Mural Oncology shares By Investing.com - Investing.com Nigeria
Goldman Sachs reports dealings in Mural Oncology shares - Investing.com
BlackRock discloses stake in Mural Oncology plc By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology plc - Investing.com
BlackRock reports stake in Mural Oncology By Investing.com - Investing.com Canada
BlackRock reports stake in Mural Oncology - Investing.com
56,176 Shares in Mural Oncology plc (NASDAQ:MURA) Purchased by Raymond James Financial Inc. - Defense World
Layoff Tracker: IGM Axes 80% of Workforce - BioSpace
Mural Oncology Plc (MURA) 재무 분석
Mural Oncology Plc (MURA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.89%
3.74%
자본화:
|
볼륨(24시간):